Kosan BioSciences -- KOSN Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Kosan BioSciences -- KOSN

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: keokalani'nui who wrote (856)	12/10/2007 1:19:44 PM
From: Icebrg	Read Replies (1) of 933

-31% seems excessive. Anyone hear anything else? Yes resp. "it seems so". I can't really figure out what went wrong here. The company has a relatively "broad" portfolio of drugs and indications. These type of falls have however a tendency to feed themselves. The sales volume is not at all excessive. Now standing at around 600.000 shares corresponding to say 2,4 mUSD. The total number of outstanding shares is 42,6 million. Erik

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next